Skip to main content
Log in

Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Plasma concentrations of caffeine and theophylline were simultaneously determined in 17 preterm infants after oral administration of aminophylline for treatment of apnoea. The ratio of caffeine/theophylline concentration in plasma increased during the first 2 weeks of treatment, owing to the longer time required for caffeine than for theophylline to reach steady state. The caffeine/theophylline ratio at steady state was 0.57±0.03 (mean±SE). Thus, caffeine contributed significantly to the total methylxanthine load in the infants. The plasma clearance of theophylline was calculated from the plasma steady state concentrations. In 3 preterm infants treated with oral aminophylline, repeated sampling showed an approximately linear increase in clearance with time from 16.8±0.4 (mean±SE) at a postnatal age of 6–11 days to 30.9±2.5 ml/kg/h at 64–69 days. In 1 full-term infant treated with oral theophylline from 3.5 to 11.5 months of age, the plasma clearance of theophylline increased in a roughly linear manner, reaching a plateau of about 100 ml/kg/h at 6–7 months of age. This corresponds to the clearance found in 1–4 year old infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aldridge A, Aranda JV, Neims AH (1979) Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447–453

    Google Scholar 

  • Aranda JV, Sitar DS, Parsons W, Loughnan PM, Neims AH (1976) Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 295: 413–416

    Google Scholar 

  • Aranda JV, Turmen T (1979) Methylxanthines in apnoea of prematurity. Clin Perinatol 6: 87–108

    Google Scholar 

  • Aranda JV, Cook CE, Gorman W, Collinge JM, Loughnan PM, Outerbridge EW, Aldridge A, Neims AH (1979) Pharmacokinetic profile of caffeine in the premature newborn with apnoea. J Pediatr 94: 663–668

    Google Scholar 

  • Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1978) Biotransformation of theophylline to caffeine in premature newborn. Lancet 2: 1204–1205

    Google Scholar 

  • Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1979) Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 94: 988–993

    Google Scholar 

  • Brazier J-L, Renaud H, Ribou B, Salle BL (1979) Plasma xanthine levels in low birthweight infants treated or not treated with theophylline. Arch Dis Child 54: 194–199

    Google Scholar 

  • Cottancin G, Baltassat P, Bory C, Challamel M-J, Frederich A (1977) Pharmacocinétique de la théophylline chez le noveauné de petit poids de naissance. Pédiatrie 32: 677–684

    Google Scholar 

  • Floberg S, Lindström B, Lönnerholm G (1980) Simultaneous determination of theophylline and caffeine after extractive alkylation in small volumes of plasma by gas chromatography — mass spectrometry. J Chromatogr 221: 166–169

    Google Scholar 

  • Giacoia G, Jusko WJ, Menke J. Koup JR (1976) Theophylline pharmacokinetics in premature infants with apnoea. J Pediatr 89: 829–832

    Google Scholar 

  • Kuzemko JA, Paala J (1973) Apnoeic attacks in the newborn treated with aminophylline. Arch Dis Child 48: 404–406

    Google Scholar 

  • Loughnan PM, Sitar DS, Ogilvie RI, Eisen A, Fox Z, Neims AH (1976) Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 88: 874–879

    Google Scholar 

  • Ogilvie RI (1978) Clinical pharmacokinetics of theophylline. Clin Pharmacokinet 3: 267–293

    Google Scholar 

  • Peabody J, Neese AL, Lucey JG, Philip AGS, Soyka LF (1977) Decreased hypoxic, hyperoxic and bradycardic episodes as responses of neonates to theophylline. Pediatr Res 11: 419

    Google Scholar 

  • Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moglan FMB (1975) Prevention of apnoea and bradycardia in low-birth-weight infants. Pediatrics 55: 589–594

    Google Scholar 

  • Soyka LF, Neese AL (1978) Perinatal exposure to methylxanthines: Possible effects on pregnancy outcome. Clin Pharmacol Ther 23: 130

    Google Scholar 

  • Takieddine FN, Tserng K-Y, King KC, Kalhan SC (1981) Postnatal development of theophylline metabolism in preterm infants. Semin Perionatol 5: 351–358

    Google Scholar 

  • Turmen T, Davis J, Aranda JV (1981) Relationship of dose and plasma concentration of caffeine and ventilation in neonatal apnoea. Semin Perinatol 5: 326–331

    Google Scholar 

  • Uauy R, Shapiro D, Smith B, Warshaw J (1975) Effect of theophylline on severe primary apnoea of prematurity. A preliminary report. Pediatrics 55: 595–598

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lönnerholm, G., Lindström, B., Paalzow, L. et al. Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life. Eur J Clin Pharmacol 24, 371–374 (1983). https://doi.org/10.1007/BF00610057

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00610057

Key words

Navigation